
Unique series of workshops in partnership with the European Medicines Agency (EMA)
7 Feb 2024

EORTC launches a prominent clinical trial in older patients with locally advanced (LA) HNSCC (Head and Neck Squamous Cell Carcinoma)
14 Dec 2023

Seven IMMUcan abstracts selected for ESMO Immuno-Oncology Congress 2023
6 Dec 2023

EORTC Quality of Life measures integrated in CDISC
20 Nov 2023

EORTC and Immunocore are collaborating to launch the ATOM clinical trial of tebentafusp in Adjuvant Uveal Melanoma
7 Nov 2023

Treatment with decitabine resulted in a similar survival and fewer adverse events compared with conventional chemotherapy in older fit patients with acute myeloid leukaemia
31 Oct 2023

New results and forthcoming EORTC trials in rare cancers, lung, head and neck, and breast carcinomas presented at ESMO 2023
20 Oct 2023

EORTC & the Menarini Group Launch New Clinical Trial in Early-Stage Breast Cancer
19 Oct 2023